Skip to content
Forest Global Training Partners
Home Services AI Governance AI Navigators Contact Us
AI Navigators AI Use CasesAI RisksAI Hallucinations Topics Entities Sources
  1. Home
  2. AI Risks
  3. FDA Issues Draft Guidances on AI in Medical Devices, Drug…

AI Risks January 14, 2025 · Fenwick

FDA Issues Draft Guidances on AI in Medical Devices, Drug Development - Fenwick

The guidances emphasize the need for comprehensive AI policies addressingriskevaluation, data management, transparency, validation, and …

Read the original at Fenwick ↗

Topics
HealthcareMarkets & Investment
Mentions
FDA
Tags
AI Use Case
Tracked via
Google Alert “AI Risks”

Related articles

  • FDA Issues Draft Guidance onAIUse in Medical Products - The National Law Review AI Risks · Jan 21, 2025
  • FDA Issues Draft Guidance onAI-Enabled Medical Devices AI Risks · Feb 17, 2025
  • FDA Issues Draft Guidance on Managing Cybersecurity Risks AffectingAI-Enabled Devices AI Risks · Feb 12, 2025
  • FDA Issues New Recommendations on Use of AI for Medical Devices, Drugs, and Biologics AI Risks · Jan 22, 2025
  • FDA RevealsAIDevelopment Cheat Sheet in Highly Anticipated Draft Guidances AI Risks · Feb 24, 2025
  • FDA to hopeful marketers ofAI-equipped medical devices: Think beyond your initial approval AI Risks · Jan 07, 2025

AI Navigators is a curated research index from Forest Global Training Partners. Articles belong to their publishers; we link to and summarize them.

Contact